Market closed
Treace Medical Concepts/$TMCI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Treace Medical Concepts
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Ticker
$TMCI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
477
ISIN
US89455T1097
Website
TMCI Metrics
BasicAdvanced
$423M
-
-$0.85
0.80
-
Price and volume
Market cap
$423M
Beta
0.8
52-week high
$10.79
52-week low
$4.54
Average daily volume
512K
Financial strength
Current ratio
4.504
Quick ratio
3.231
Long term debt to equity
63.876
Total debt to equity
65.847
Interest coverage (TTM)
-9.95%
Management effectiveness
Return on assets (TTM)
-14.56%
Return on equity (TTM)
-45.73%
Valuation
Price to revenue (TTM)
1.987
Price to book
4.01
Price to tangible book (TTM)
4.99
Price to free cash flow (TTM)
-11.334
Growth
Revenue change (TTM)
7.54%
Earnings per share change (TTM)
-4.03%
3-year revenue growth (CAGR)
26.25%
3-year earnings per share growth (CAGR)
18.19%
What the Analysts think about TMCI
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Treace Medical Concepts stock.
TMCI Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
TMCI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
TMCI News
AllArticlesVideos
Levi & Korsinsky Urges Treace Medical Concepts, Inc. (TMCI) Shareholders to Act Before Lead Plaintiff Deadline June 10, 2025
Accesswire·8 hours ago
Investors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025
Accesswire·12 hours ago
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI
Accesswire·12 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Treace Medical Concepts stock?
Treace Medical Concepts (TMCI) has a market cap of $423M as of May 16, 2025.
What is the P/E ratio for Treace Medical Concepts stock?
The price to earnings (P/E) ratio for Treace Medical Concepts (TMCI) stock is 0 as of May 16, 2025.
Does Treace Medical Concepts stock pay dividends?
No, Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Treace Medical Concepts dividend payment date?
Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders.
What is the beta indicator for Treace Medical Concepts?
Treace Medical Concepts (TMCI) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.